PLRX
PLIANT THERAPEUTICS, INC.
Key Financials
Revenue
$0
NaN%
Operating Income
$-156373000
↑ 31.5%
Net Income
$-149344000
↑ 29.0%
EPS (Diluted)
$-2.43
↑ 30.0%
Total Liabilities
$44.0M
↓ 52.6%
Cash & Equivalents
$45.4M
↓ 36.2%
Long-term Debt
$0.00
↓ 100.0%
Shareholders' Equity
$181.2M
↓ 40.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| 3 | 7/13/2026 | View on SEC |
| 4 | 7/13/2026 | View on SEC |
| 3 | 7/13/2026 | View on SEC |
| 4 | 7/13/2026 | View on SEC |
| 8-K | 7/13/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PLRX |
| Company Name | PLIANT THERAPEUTICS, INC. |
| CIK | 1746473 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-481-6770 |